SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-178866
Filing Date
2022-06-22
Accepted
2022-06-22 17:07:55
Documents
12
Period of Report
2022-06-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d303581d8k.htm   iXBRL 8-K 75565
  Complete submission text file 0001193125-22-178866.txt   205622

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA srra-20220622.xsd EX-101.SCH 2867
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20220622_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20220622_pre.xml EX-101.PRE 11269
6 EXTRACTED XBRL INSTANCE DOCUMENT d303581d8k_htm.xml XML 3340
Mailing Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404
Business Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404 (605) 376-8679
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37490 | Film No.: 221032792
SIC: 2834 Pharmaceutical Preparations